Browse > Article

Systemic Availability and Pharmacokinetics of Surfactin, a Lipopeptide Produced by Bacillus subtilis BC1212 in Rats  

Lim Jong-Hwan (B&C Biopharm)
Kim Myoung-Seok (College of Veterinary Medicine, Chungnam National University)
Park Byung-Kwon (College of Veterinary Medicine, Chungnam National University)
Hwang Youn-Hwan (College of Veterinary Medicine, Chungnam National University)
Hwang Mi-Hyun (College of Veterinary Medicine, Kyoungbuk National University)
Park Seung-Chun (College of Veterinary Medicine, Kyoungbuk National University)
Yun Hyo-In (College of Veterinary Medicine, Chungnam National University)
Publication Information
Toxicological Research / v.21, no.4, 2005 , pp. 319-323 More about this Journal
Abstract
The aim of the present study was to evaluate systemic bioavailability of surfactin and to determine its pharmacokinetic profiles. The stability of surfactin to pH, temperature and protease was evaluated. Surfactin was resistant to high temperature, a wide range of pH and the action of hydrolytic enzymes. The pharmacokinetic natures of surfactin which were shown the short half-life, rapid clearance and poor bioavailability. The results of study should provide preliminary data of surfactin for further dose-finding studies and for the design of application forms. It is also be important to a context of the safety of surfactin.
Keywords
Surfactin; Bacillus subtilis; Pharmacokinetics; Bioavailability; Stability;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Baumgart, F., Kluge, B., Ullrich, C., Vater, J. and Ziessow, D. (1991): Identification of amino acid substitutions in the lipopeptide surfactin using 2D NMR spectroscopy. Biochem. Biophys. Res. Commun., 177, 998-1005   DOI   ScienceOn
2 Kanatomo, S., Nagai, S., Ohki, K. and Yasuda, Y. (1995): Study on surfactin, a cyclic depsipeptide. I. Isolation and structure of eight surfuctin analogs produced by Bacillus natto KMD2311. Yakugaku Zasshi, 115, 756-764   DOI
3 Kowall, M., Vater, J., Kluge, B., Stein, T., Franke, P. and Ziessow, D. (1998): Separation and characterization of surfactin isoforms produced by Bacillus subtilis OKB-105. J. Colloid. Interface Sci., 204, 1-8   DOI   ScienceOn
4 Vollenbroich, D., Ozel, M., Vater, J., Kamp, R.M. and Pauli, G. (1997a): Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals, 25, 289-297   DOI   ScienceOn
5 Peypoux, F., Bonmatin, J.M. and Wallach, J. (1999): Recent trends in the biochemistry of surfactin. Appl. Microbiol. Biotechnol., 51, 553-563   DOI   ScienceOn
6 Hamman, J.H., Enslin, G.M. and Kotze, A.F. (2005): Oral delivery of peptide drugs: barriers and developments. BioDrugs, 19, 165-177   DOI   ScienceOn
7 Arima, K., Kakinuma, A. and Tamura, G. (1968): Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem. Biophys. Res. Commun., 31, 488-494   DOI   ScienceOn
8 Froyshov, O., Pedersen, S. and Hove, K. (1986): Absorption, metabolism and excretion of zinc $C^{14}$-bacitracin fed to young pigs. J. Anim. Physiol. Anim. Nutr., 55, 100-110   DOI
9 Desai, J.D. and Banat, I.M. (1997): Microbial production of surfactants and their commercial potential. Microbiol. Mol. Biol. Rev., 61, 47-64
10 Kikuchi, T. and Hasumi, K. (2002): Enhancement of plasminogen activation by surfactin C: augmentation of fibrinolysis in vitro and in vivo. Biochim. Biophys. Acta, 1596, 234-245
11 Sullivan, E.R. (1985): Molecular genetics of biosurfactants production. Curr. Opin. Biotechno., 9, 263-269
12 LeCluyse, E.L. and Sutton, S.C. (1997): In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement. Adv. Drug Deliv. Rev., 23, 163-183   DOI   ScienceOn
13 Bonmatin, J.M., Genest, M., Labbe, H. and Ptak, M. (1994): Solution three-dimensional structure of surfactin: a cyclic lipopeptide studied by 1H-NMR, distance geometry, and molecular dynamics. Biopolymers, 34, 975-986   DOI   ScienceOn
14 Grangemard, I., Bonmatin, J.M., Bernillon, J., Das, B.C. and Peypoux, F. (1999): Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis 1M 1307: production, isolation and structural evaluation by NMR and mass spectrometry. J. Antibiot., 52, 363-373   DOI
15 Lee, V.H.L. (1990): Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Control Release, 13, 213-223   DOI   ScienceOn
16 Donoso, G., Craig, G.O. and Baldwin, R.S. (1970): The distribution and excretion of zinc $bacitracin-^{14}C$ in rats and swine. Toxicol. Appl. Pharmacol., 17, 366-374   DOI   ScienceOn
17 Singh, P. and Cameotra, S.S. (2004): Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol., 22, 142-146   DOI   ScienceOn
18 Vollenbroich, D., Pauli, G., Ozel, M. and Vater, J. (1997b): Antimycoplasma properties and application in cell culture of surfactin, a Iipopeptide antibiotic from Bacillus subtilis. Appl. Environ. Microbiol., 63, 44-49